Drug or treatment
Felzartamab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Felzartamab that are recruiting, at sites in 30 countries (most in United States (4), Argentina (3), Australia (3)). By phase: Phase 3 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 30Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Felzartamab for Graves’ Disease: See if it helps control thyroids and reduce need for ATDs | Phase 2 | Glendale, Arizona and 13 other locations | Recruiting | Jul 23, 2026 |
| Felzartamab infusions for adults with kidney transplants and late isolated microvascular inflammation | Phase 2 | Loma Linda, California and 52 other locations | Recruiting | Oct 21, 2025 |
| Felzartamab infusions for adults with primary membranous nephropathy | Phase 3 | Huntsville, Alabama and 116 other locations | Recruiting | May 8, 2025 |
| Effects of Felzartamab on Adults with Immunoglobulin A Nephropathy | Phase 3 | Little Rock, Arkansas and 264 other locations | Recruiting | Apr 20, 2025 |
All recruiting trials (4)
-
Felzartamab for Graves’ Disease: See if it helps control thyroids and reduce need for ATDs
This study tests felzartamab vs placebo in adults with Graves’ disease to see if it can normalize thyroid hormones and let people stop anti-thyroid drugs.
-
Felzartamab infusions for adults with kidney transplants and late isolated microvascular inflammation
This study will try felzartamab infusions in adults with kidney transplants who developed late isolated microvascular inflammation to see if the inflammation goes away after 24 weeks.
-
Felzartamab infusions for adults with primary membranous nephropathy
This study tests whether felzartamab infusions help adults with primary membranous nephropathy reach complete remission of proteinuria compared with tacrolimus.
-
Effects of Felzartamab on Adults with Immunoglobulin A Nephropathy
This study is testing if felzartamab infusions can help adults with immunoglobulin A nephropathy reduce protein in their urine and improve kidney function.
Quick answers
How many clinical trials of Felzartamab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 30 countries. The most sites are in United States (4 trials), Argentina (3 trials), Australia (3 trials), Brazil (3 trials), Canada (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.